Literature DB >> 1545029

MRI of primary spleen angiosarcoma with iron accumulation.

K Kaneko1, H Onitsuka, J Murakami, H Honda, M Kimura, N Shiraishi, K Masuda.   

Abstract

A case of splenic angiosarcoma with siderotic nodules is reported. The tumor was hyperechoic on ultrasound and had high density on CT and very low intensity on MR. Gandy-Gamna nodules (siderotic nodules) were demonstrated histopathogically.

Entities:  

Mesh：

Substances：

Year:  1992        PMID： 1545029     DOI： 10.1097/00004728-199203000-00021

Source DB:  PubMed          Journal:  J Comput Assist Tomogr        ISSN： 0363-8715            Impact factor:   1.826


  6 in total

Review 1.  Imaging patterns in non-traumatic spleen lesions in adults-a review.

Authors:  Matthew Tan; Hsien Min Low; Vishalkumar Shelat; Cher Heng Tan
Journal:  Jpn J Radiol       Date:  2022-01-31       Impact factor: 2.374

2.  An 18-year-old female with recurrent esophageal variceal bleeding.

Authors:  Omar J Shah; Parveen Shah; Irfan Robbani; Farooq Mir; Parvez Nazir
Journal:  Ann Saudi Med       Date:  2009 Jan-Feb       Impact factor: 1.526

Review 3.  Primary splenic angiosarcoma with liver metastasis: A case report and literature review.

Authors:  Kai-Feng Yang; Yong Li; De-Long Wang; Jun-Wu Yang; Sen-Yan Wu; Wei-Dong Xiao
Journal:  World J Gastroenterol       Date:  2016-03-28       Impact factor: 5.742

4.  Tumours of the spleen.

Authors:  Andrea Giovagnoni; Chiara Giorgi; Gaia Goteri
Journal:  Cancer Imaging       Date:  2005-07-25       Impact factor: 3.909

5.  Magnetic resonance susceptibility-weighted imaging versus other imaging modalities in detecting splenic siderotic lesions.

Authors:  Chuanming Li; Daiquan Zhou; Jun Zhao; Xin Wang; Wei Mu; Jian Wang
Journal:  PLoS One       Date:  2013-09-09       Impact factor: 3.240

Review 6.  Pediatric primary splenic angiosarcoma: an aggressive multidisciplinary approach to the oncologic management of a rare malignancy.

Authors:  Oscar K Serrano; Esther Knapp; Kevin Huang; Galina Baran; Mindy Statter; Danielle McClain; Jonathan Gill
Journal:  World J Surg Oncol       Date:  2014-12-09       Impact factor: 2.754
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.